Skip to main content
. 2020 Aug 7;26(29):4343–4355. doi: 10.3748/wjg.v26.i29.4343

Table 2.

Smoking habits and use of alternative smoking products based on type of diagnosis

Questionnaire items Crohn’s disease Ulcerative colitis P value1
Smoking habits and use of an alternative smoking product
Current cigarettes smoker
Yes 268/425 (63.1) 187/346 (54.1) 0.012
No 157/425 (36.9) 159/346 (45.9)
Duration of cigarette smoking (yr)
< 1 22/410 (5.4) 26/317 (8.2) 0.13
1-5 46/410 (11.2) 47/317 (14.8)
6-10 69/410 (16.8) 56/317 (17.7)
> 10 273/410 (66.6) 188/317 (59.3)
Extent of cigarette smoking (cigarettes per day)
< 1 12/425 (2.8) 22/341 (6.5) < 0.001
1-5 51/425 (12.0) 67/341 (19.6)
6-10 120/425 (28.3) 106/341 (31.1)
11-20 179/425 (42.1) 113/341 (33.1)
> 20 63/425 (14.8) 33/341 (9.7)
Current use of an alternative smoking product
Yes 343/427 (80.3) 282/355 (79.4) 0.79
No 84/427 (19.7) 73/355 (20.6)
Type of smoking/nicotine product ever used
Cigarettes 409/427 (95.8) 330/355 (93.0) 0.11
E-cigarettes 84/427 (19.7) 71/355 (20.0) 0.93
Heat not burn tobacco product 19/427 (4.5) 25/355 (7.0) 0.12
Nicotine gum 37/427 (8.7) 36/355 (10.1) 0.54
Nicotine patches 21/427 (4.9) 23/355 (6.5) 0.35
Chewing tobacco/snus/snuff 10/427 (2.3) 15/355 (4.2) 0.16
Cigars 44/427 (10.3) 31/355 (8.7) 0.47
Pipes 13/427 (3.0) 8/355 (2.3) 0.66
Marijuana 81/427 (19.0) 56/355 (15.8) 0.26
Any other combustion/smoking product 11/427 (2.6) 5/355 (1.4) 0.31
None of the above 2/427 (0.5) 7/355 (2.0) 0.09
Ever stopped cigarette smoking and restarted
Yes 264/426 (62.0) 253/346 (73.1) 0.001
No 162/426 (38.0) 93/346 (26.9)
Ever user of an alternative smoking product
Yes 215/427 (50.4) 196/354 (55.4) 0.17
No 212/427 (49.6) 158/354 (44.6)
Current use of an alternative smoking product
Yes 84/427 (19.7) 73/355 (20.6) 0.79
No 343/427 (80.3) 282/355 (79.4)
Duration of use of alternative smoking products
< 1 44/76 (55.3) 46/81 (56.7) 0.33
1-5 23/76 (30.3) 16/81 (19.8)
6-10 10/76 (13.1) 16/81 (19.8)
> 10 1/76 (1.3) 3/81 (3.7)
Started cigarette smoking
Before IBD diagnosis 392/426 (92.0) 290/343 (84.6) 0.001
After IBD diagnosis 34/426 (8.0) 53/343 (15.4)
Stopped cigarette smoking
Before IBD diagnosis 85/250 (34.0) 146/247 (59.1) < 0.001
After IBD diagnosis 165/250 (66.0) 101/247 (40.9)
Restarted cigarette smoking
Before IBD diagnosis 89/260 (34.2) 66/243 (27.2) 0.10
After IBD diagnosis 171/260 (65.8) 177/243 (72.8)
Started using an alternative smoking product
Before IBD diagnosis 85/210 (40.5) 85/185 (46.0) 0.31
After IBD diagnosis 125/210 (59.5) 100/185 (54.0)
Switched from cigarette smoking to using an alternative smoking product
Before IBD diagnosis 77/207 (37.2) 81/184 (44.0) 0.18
After IBD diagnosis 130/207 (62.8) 103/184 (56.0)

The survey had a hierarchical structure, meaning that only patients who answered to certain items could answer to other following questions. For this reason, the denominator for several questions is different. In some cases, the patient did not answer and this can result in a missing value. We have transparently declared in our tables the denominator we have used to calculate the proportion of patients giving certain answers.

1

Fisher’s exact test. IBD: Inflammatory bowel diseases.